Immunic, Inc.
IMUX
$1.12
-$0.03-2.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.37% | 24.60% | 24.94% | 21.58% | 22.25% |
| Total Depreciation and Amortization | 20.72% | 14.02% | 26.67% | 19.32% | 44.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 97.29% | -65.39% | -67.73% | -67.98% | -83.30% |
| Change in Net Operating Assets | -96.25% | -56.02% | -41.33% | -47.36% | 57.90% |
| Cash from Operations | -19.68% | -5.46% | -6.09% | -17.68% | -8.73% |
| Capital Expenditure | 20.96% | -153.57% | -113.20% | -27.94% | -198.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | 203.99% | 201.73% |
| Cash from Investing | -102.79% | -42,500.00% | -1,300.00% | 193.22% | 197.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.48% | -98.66% | -98.21% | -98.33% | -98.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7,115.97% | 32.93% | 34.10% | 14.02% | -98.92% |
| Foreign Exchange rate Adjustments | -297.33% | -75.79% | -115.00% | 139.22% | 126.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.68% | 95.28% | 122.29% | 254.32% | -402.14% |